Adenoviral vector-based vaccine platform for COVID-19: Current status

VP Chavda, R Bezbaruah, D Valu, B Patel, A Kumar… - Vaccines, 2023 - mdpi.com
The coronavirus disease (COVID-19) breakout had an unimaginable worldwide effect in the
21st century, claiming millions of lives and putting a huge burden on the global economy …

[HTML][HTML] Rheumatoid Arthritis and COVID-19 at the Intersection of Immunology and Infectious Diseases: A Related PRISMA Systematic Literature Review

AI Vlădulescu-Trandafir, VC Bo**că… - International Journal of …, 2024 - mdpi.com
Rheumatoid arthritis (RA) patients face different health challenges when infected with
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) than the general …

Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review

A Stainer, A Tonutti, M De Santis, F Amati… - Frontiers in …, 2023 - frontiersin.org
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by
synovitis as the most common clinical manifestation, and interstitial lung disease (RA-ILD) …

The third dose of BNT162b2 COVID-19 vaccine does not “boost” disease flares and adverse events in patients with rheumatoid arthritis

A Picchianti Diamanti, A Navarra, G Cuzzi, A Aiello… - Biomedicines, 2023 - mdpi.com
Data on the risk of adverse events (AEs) and disease flares in autoimmune rheumatic
diseases (ARDs) after the third dose of COVID-19 vaccine are scarce. The aim of this …

Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study

R Naveen, E Nikiphorou, M Joshi, P Sen… - …, 2023 - academic.oup.com
Objective To determine COVID-19 vaccine-related adverse events (AEs) in the seven-day
post-vaccination period in patients with SLE vs autoimmune rheumatic diseases (AIRDs) …

COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey

M Dey, B Doskaliuk, I Parodis, J Lindblom… - Rheumatology …, 2024 - Springer
This study aimed to assess COVID-19 vaccination-related AEs in patients with rheumatoid
arthritis (RA), in the COVID-19 Vaccination in Autoimmune Diseases (COVAD)-2 study. An …

[HTML][HTML] Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination

JW Kim, JY Jung, CH Suh, YM Ye… - Journal of Korean …, 2023 - synapse.koreamed.org
Background This study aimed to compare the occurrence of adverse events (AEs) and
disease flares after vaccination against coronavirus disease 2019 (COVID-19) and influenza …

Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohort

S Panchawagh, D Bohdana, M Kuwana… - Rheumatology …, 2023 - Springer
Data on short-term safety of COVID-19 vaccination in patients with systemic sclerosis (SSc)
were explored previously in the first COVID-19 vaccination in autoimmune diseases …

Knowledge map** of COVID-19 and autoimmune diseases: a visual and bibliometric analysis

Y Zhang, Z Jia, X **a, J Wang - Clinical and Experimental Medicine, 2023 - Springer
Background Many studies have shown an association between COVID-19 and autoimmune
diseases (ADs). Studies on COVID-19 and ADs have also increased significantly, but there …

Digital Health and Self-Management in Idiopathic Inflammatory Myopathies: A Missed Opportunity?

S Battista, B Giardulli, C Sieiro Santos… - Current rheumatology …, 2024 - Springer
Abstract Purpose of Review This paper explored the potential of digital health in idiopathic
inflammatory myopathies (IIMs), with a focus on self-management. Digital self-management …